ScreenPoint Medical

ScreenPoint Medical’s flagship algorithm, Transpara, is the leading breast AI for early breast cancer detection and diagnosis.

[ScreenPoint Medical @screenpointmed]

We’ll be at #SBI 2026 in Seattle this Thursday and are excited to welcome you to Booth 415 from 16–19 April. Visit our booth to discover how #Transpara® is advancing #BreastAI and helping improve reading efficiency in breast screening workflows.

[ScreenPoint Medical @screenpointmed]

Transpara® will be at the Society of Breast Imaging Annual Symposium (SBI) 2026 this April in Seattle, Washington!

More on our program in this blog: https://t.co/kxugKwV46u

#SBI #Seattle #Radiology #Mammography

See you there!

[ScreenPoint Medical @screenpointmed]

Nearly 4 out of 5 practices report a shortage of breast imaging radiologists, according to a 2026 survey. As screening demand continues to grow, many breast imaging services are under increasing pressure to maintain timely, high-quality care.

https://t.co/J0eAxQnfD5

[ScreenPoint Medical @screenpointmed]

On International Women’s Day, the German Roentgen Society’s (DRG) new “Radiology and Women’s Health” campaign, endorsed by Dr. Christiane Kuhl, is an important reminder of the critical role radiology plays in women’s care.

https://t.co/QExSbee29r

#GiveToGain #IWD #IWD2026

[ScreenPoint Medical @screenpointmed]

ScreenPoint Medical will be at ECR 2026 in Vienna, March 4–7! Join us at Booth D-16 (Expo Foyer D, Level -2) to experience the Transpara® Breast AI Suite in action.

Read our blog for full details and schedule your personalised demo https://t.co/Qtix1O85Qc

[ScreenPoint Medical @screenpointmed]

Our founders, Prof. Nico Karssemeijer and Prof. Sir Michael Brady, continue to inspire with the Honorary Beaver Award and election to the National Academy of Engineering Class of 2026, respectively.

https://t.co/BhONeKHp3U

[ScreenPoint Medical @screenpointmed]

Year of the Fire Horse brings focus, pace, and a refusal to stand still.

These are qualities that feel particularly relevant in women’s health, where progress cannot afford to be slow.

Here’s to a year defined not by slogans, but by measurable steps forward for women’s health.

[ScreenPoint Medical @screenpointmed]

Around the world, around the world! 🌏🌍🌎

From leading newsrooms to top scientific forums, EVERYONE is talking about the #MASAI Trial and its enormous promise for women’s health. https://t.co/ace48Q88U0

[ScreenPoint Medical @screenpointmed]

On World Cancer Day, we stand with all those affected, honoring survivors, remembering those we've lost, and supporting fighters everywhere.

Let’s continue raising awareness and advocating for early screening, which can save lives.

#WorldCancerDay #CancerAwareness

[ScreenPoint Medical @screenpointmed]

FINAL RESULTS FROM THE MASAI TRIAL!

The world's first Randomized Controlled Trial for breast cancer detection AI has published its results on the use of Transpara®.

Retrospective studies showed promise, but now you can see the gold-standard proof.
https://t.co/HQJ4eDk6Hc

[ScreenPoint Medical @screenpointmed]

This year, the $16M PRISM Randomized Controlled Trial (RCT) begins, marking a groundbreaking step in breast cancer screening.

More about the trial? https://t.co/SFSdLvQQih

[ScreenPoint Medical @screenpointmed]

The new year comes with new announcement: ScreenPoint Medical is partnering with Ferrum Health to make the Transpara® Breast AI Suite available through Ferrum’s Model Hub including #Transpara Detection, Density, and Temporal Comparison.

Read more here: https://t.co/msd3zUPxRl

[ScreenPoint Medical @screenpointmed]

2026 is here and so are our TOP stories from last year!

We’ve packed it into a fast, fun recap with cost savings, clinical wins, global headlines, and big leaps for #Transpara.

Check out our quick highlight reel and get inspired for the year ahead: https://t.co/lTpId33Byu

[ScreenPoint Medical @screenpointmed]

#RSNA2025: Amid all the buzz of RSNA, find clarity on faster, more efficient, and more confident breast cancer screening and diagnosis. Visit us at Booth 4719.

https://t.co/FrZ4uADHjf

[ScreenPoint Medical @screenpointmed]

Join us at our booth for a series of #Transpara Clinical Chats featuring leading experts in breast imaging.

For details and the full schedule, visit our #RSNA2025 page and add the clinical chats to your calendar: https://t.co/GK9y3I8uG4

#BreastImaging #Radiology #HealthAI

[ScreenPoint Medical @screenpointmed]

#RSNA2025: Meet our co-founder Nico Karssemeijer at our booth 4719 in the South Hall for a clinical chat!

When: Sunday, November 30, 1:00-2:00 PM CT
Where: Booth 4719, South Hall

Visit our RSNA page at https://t.co/tPbk2T8q7l to learn more and add this session to your calendar.

[ScreenPoint Medical @screenpointmed]

#RSNA2025: We're presenting research on AI advancements in breast cancer detection!

Visit our dedicate RSNA page at https://t.co/T5Nqp4k7XZ for full details on our presentations and programs at the event.

#BreastAI #RSNA #MedicalImaging #MedTech

[ScreenPoint Medical @screenpointmed]

Transpara® Breast AI is now integrated into RAYUS Radiology's mammography screening services in its Washington State clinics, bringing the technology to patients across the Pacific Northwest.

More about this milestone: https://t.co/FrbQzFtLBz

[ScreenPoint Medical @screenpointmed]

And before you know it, #Transpara by ScreenPoint Medical is back at #RSNA 2025, the world’s largest radiology conference!

Booth #4719, South Hall, McCormick Place, Chicago, USA
Nov 30–Dec 4, 2025

A personalized demo just for you? https://t.co/iJsD2cG19R

[ScreenPoint Medical @screenpointmed]

Two of our engineers returned from #MICCAI 2025 in South Korea, where they presented their accepted abstracts!

“Unsupervised Image-Based Prompting for Lesion Matching Across Mammography Views” and "Explainable Mammography Through Foundation Model for k-NN Retrieval".